STEPHENS INC /AR/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 230 filers reported holding MYRIAD GENETICS INC in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2019$1,221,000
-9.2%
42,647
-11.8%
0.03%
-10.0%
Q2 2019$1,344,000
-12.7%
48,367
+4.3%
0.03%
-18.9%
Q1 2019$1,539,000
+25.5%
46,370
+10.0%
0.04%
+5.7%
Q4 2018$1,226,000
-41.5%
42,169
-7.4%
0.04%
-32.7%
Q3 2018$2,096,000
-73.6%
45,558
-85.2%
0.05%
-81.0%
Q2 2017$7,944,000
+9.5%
307,413
-18.6%
0.27%
+3.4%
Q1 2017$7,254,000
+40.1%
377,799
+21.7%
0.26%
+25.1%
Q4 2016$5,176,000
+258.4%
310,496
+342.6%
0.21%
+234.9%
Q3 2016$1,444,000
+3422.0%
70,156
+5096.7%
0.06%
+3050.0%
Q2 2016$41,000
-78.4%
1,350
-73.5%
0.00%
-77.8%
Q1 2016$190,000
-23.7%
5,085
-11.8%
0.01%
-25.0%
Q4 2015$249,000
+77.9%
5,765
+53.9%
0.01%
+71.4%
Q3 2015$140,000
+677.8%
3,745
+613.3%
0.01%
+600.0%
Q2 2015$18,000
-95.2%
525
-95.0%
0.00%
-94.1%
Q1 2015$374,000
+663.3%
10,560
+638.5%
0.02%
+750.0%
Q4 2014$49,000
+8.9%
1,430
+22.7%
0.00%0.0%
Q3 2014$45,000
-74.7%
1,165
-74.5%
0.00%
-77.8%
Q2 2014$178,000
+287.0%
4,570
+238.5%
0.01%
+200.0%
Q1 2014$46,000
+64.3%
1,3500.0%0.00%
+200.0%
Q4 2013$28,000
-22.2%
1,350
-12.9%
0.00%
-50.0%
Q3 2013$36,000
-71.9%
1,550
-67.4%
0.00%
-71.4%
Q2 2013$128,0004,7500.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders